MedTrace Logo

Survival Outcomes of Multiple Myeloma Patients Admitted on Assiut Clinical Hematology Unit

NCT05119205 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2021-11-22

No results posted yet for this study

Summary

Our study will discuss survival outcomes of multiple myeloma patients admitted on Assiut clinical Hematology and role of neutrophil to lymphocyte and lymphocyte to monocyte ratios as prognostic factors in multiple myeloma.

Conditions

  • Multiple Myeloma Survival Outcome

Interventions

DIAGNOSTIC_TEST

Bone marrow biopsy and compete blood count

Bone marrow biopsy and compete blood count will be done for follow up in patients with multiple myeloma

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2024-01-31
Completion
2024-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05119205 on ClinicalTrials.gov